Tart Cherry Extract for Gout: Limited Evidence Does Not Support Its Use as Primary Therapy
Tart cherry extract should not be recommended as a primary or adjunctive therapy for gout management, as current evidence shows inconsistent effects on serum uric acid levels and gout flares, and it is not included in any major international gout management guidelines.
Guideline Recommendations: No Mention of Tart Cherry
The most authoritative gout management guidelines—including the 2020 American College of Rheumatology 1, 2017 EULAR 2, and 2014 multinational 3e Initiative 3—do not recommend tart cherry products for gout treatment. These guidelines consistently prioritize:
- First-line acute treatment: NSAIDs, colchicine, or corticosteroids 2, 1
- Urate-lowering therapy: Allopurinol as first-line, with febuxostat or uricosurics as alternatives 2, 1
- Lifestyle modifications: Weight loss, limiting alcohol (especially beer/spirits), reducing sugar-sweetened beverages, and avoiding excessive meat/seafood 2
The 2017 EULAR guidelines mention that "eating cherries may reduce the frequency of acute gout" based on epidemiological studies 2, but this is presented as observational data within general lifestyle advice, not as a therapeutic recommendation.
Research Evidence: Contradictory and Inconclusive
Studies Showing No Effect (Higher Quality, More Recent)
The most rigorous recent evidence demonstrates no benefit:
2020 randomized controlled trial (n=50): Tart cherry concentrate at multiple doses (7.5-30 mL twice daily for 28 days) showed no significant effect on serum uric acid, urine urate excretion, or gout flare frequency 4. This study tested dose-response relationships and found no effect at any dose level.
2026 randomized crossover trial (n=12): Single serving of tart cherry juice showed no acute effects on uric acid, vascular function, or inflammation compared to control 5. The study importantly noted that diurnal fluctuations in uric acid may explain apparent benefits in uncontrolled studies.
Studies Showing Modest Effects (Lower Quality)
Some studies report benefits, but with significant limitations:
2023 trial (n=282): Tart cherry supplementary citrate mixture showed similar urine alkalization and serum urate reduction as citrate mixture alone, but with greater reduction in inflammatory markers (CRP) and urinary albumin/creatinine ratio 6. Critical caveat: The comparison was against citrate and sodium bicarbonate—not placebo—making it impossible to isolate cherry-specific effects.
2012 case-crossover study (n=633): Cherry intake associated with 35% lower risk of gout attacks (OR 0.65) 7. Major limitation: This was an observational study subject to recall bias and confounding, not a randomized trial.
2020 pilot RCT (n=84): Cherry extract 3,600 mg/day showed reduction in gout flares compared to baseline 8. Critical flaw: No placebo control group—only comparison to diet modification.
2026 RCT (n=10): Four weeks of 500 mg tart cherry extract reduced CRP by 23% and urate by 37% 9. Major limitation: Extremely small sample size (n=10) limits generalizability.
Systematic Reviews Acknowledge Inconsistency
2019 systematic review: Found positive correlation between cherry intake and reduced gout attacks, but could not perform meta-analysis due to high methodological variation and lack of quality studies 10
2026 meta-analysis: Pooled data showed modest serum uric acid reduction (SMD -0.22), but with substantial heterogeneity and limited evidence 11
2025 systematic review: Concluded evidence is "inconclusive with only modest benefits" and called for high-quality trials 12
Safety Profile
Tart cherry extract appears generally safe with minimal adverse events reported across studies 6, 4, 8. Gastrointestinal symptoms are the most common side effect (3-28% in various studies), similar to placebo rates 8.
Clinical Bottom Line
Do not recommend tart cherry extract as gout therapy because:
No guideline support: Major international guidelines do not include it in treatment algorithms 2, 1
Inconsistent efficacy: The highest quality, most recent RCT showed no effect on the primary outcomes that matter—serum uric acid and gout flares 4
Methodological concerns: Studies showing benefits often lack placebo controls, have small sample sizes, or cannot isolate cherry-specific effects from other interventions 6, 8, 9
Proven alternatives exist: Evidence-based treatments (allopurinol, NSAIDs, colchicine) have robust efficacy data and guideline support 2, 1
If patients inquire about cherry products, explain that while generally safe, evidence does not support their use as a substitute for proven gout therapies. Focus instead on guideline-recommended treatments: initiating allopurinol (starting at 100 mg/day, titrating to target serum uric acid <6 mg/dL), using colchicine or NSAIDs for acute flares, and implementing evidence-based lifestyle modifications including weight loss, alcohol reduction, and limiting sugar-sweetened beverages 2, 1.